[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Dyspareunia Treatment Market - Global Outlook and Forecast 2021-2027

April 2021 | 94 pages | ID: DCC04E0E4503EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Dyspareunia Treatment in Global, including the following market information:

Global Dyspareunia Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Dyspareunia Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dyspareunia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dyspareunia Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Dyspareunia Treatment Market Segment Percentages, By Type, 2020 (%)
  • Medication
  • Services
China Dyspareunia Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Dyspareunia Treatment Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Clinics
Global Dyspareunia Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Dyspareunia Treatment Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Dyspareunia Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Dyspareunia Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • TherapeuticsMD Inc
  • AbbVie Inc.
  • Laboratories VIVACY
  • GTO Pharmaceutical LLC
  • Hormos Medical Oy (QuatRx Pharmaceuticals)
  • EndoCeutics Inc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Dyspareunia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Dyspareunia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DYSPAREUNIA TREATMENT OVERALL MARKET SIZE

2.1 Global Dyspareunia Treatment Market Size: 2021 VS 2027
2.2 Global Dyspareunia Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Dyspareunia Treatment Players in Global Market
3.2 Top Global Dyspareunia Treatment Companies Ranked by Revenue
3.3 Global Dyspareunia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Dyspareunia Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Dyspareunia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dyspareunia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Dyspareunia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Dyspareunia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Dyspareunia Treatment Market Size Markets, 2021 & 2027
  4.1.2 Medication
  4.1.3 Services
4.2 By Type - Global Dyspareunia Treatment Revenue & Forecasts
  4.2.1 By Type - Global Dyspareunia Treatment Revenue, 2016-2021
  4.2.2 By Type - Global Dyspareunia Treatment Revenue, 2022-2027
  4.2.3 By Type - Global Dyspareunia Treatment Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Dyspareunia Treatment Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Clinics
5.2 By Application - Global Dyspareunia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Dyspareunia Treatment Revenue, 2016-2021
  5.2.2 By Application - Global Dyspareunia Treatment Revenue, 2022-2027
  5.2.3 By Application - Global Dyspareunia Treatment Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Dyspareunia Treatment Market Size, 2021 & 2027
6.2 By Region - Global Dyspareunia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Dyspareunia Treatment Revenue, 2016-2021
  6.2.2 By Region - Global Dyspareunia Treatment Revenue, 2022-2027
  6.2.3 By Region - Global Dyspareunia Treatment Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Dyspareunia Treatment Revenue, 2016-2027
  6.3.2 US Dyspareunia Treatment Market Size, 2016-2027
  6.3.3 Canada Dyspareunia Treatment Market Size, 2016-2027
  6.3.4 Mexico Dyspareunia Treatment Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Dyspareunia Treatment Revenue, 2016-2027
  6.4.2 Germany Dyspareunia Treatment Market Size, 2016-2027
  6.4.3 France Dyspareunia Treatment Market Size, 2016-2027
  6.4.4 U.K. Dyspareunia Treatment Market Size, 2016-2027
  6.4.5 Italy Dyspareunia Treatment Market Size, 2016-2027
  6.4.6 Russia Dyspareunia Treatment Market Size, 2016-2027
  6.4.7 Nordic Countries Dyspareunia Treatment Market Size, 2016-2027
  6.4.8 Benelux Dyspareunia Treatment Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Dyspareunia Treatment Revenue, 2016-2027
  6.5.2 China Dyspareunia Treatment Market Size, 2016-2027
  6.5.3 Japan Dyspareunia Treatment Market Size, 2016-2027
  6.5.4 South Korea Dyspareunia Treatment Market Size, 2016-2027
  6.5.5 Southeast Asia Dyspareunia Treatment Market Size, 2016-2027
  6.5.6 India Dyspareunia Treatment Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Dyspareunia Treatment Revenue, 2016-2027
  6.6.2 Brazil Dyspareunia Treatment Market Size, 2016-2027
  6.6.3 Argentina Dyspareunia Treatment Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Dyspareunia Treatment Revenue, 2016-2027
  6.7.2 Turkey Dyspareunia Treatment Market Size, 2016-2027
  6.7.3 Israel Dyspareunia Treatment Market Size, 2016-2027
  6.7.4 Saudi Arabia Dyspareunia Treatment Market Size, 2016-2027
  6.7.5 UAE Dyspareunia Treatment Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 TherapeuticsMD Inc
  7.1.1 TherapeuticsMD Inc Corporate Summary
  7.1.2 TherapeuticsMD Inc Business Overview
  7.1.3 TherapeuticsMD Inc Dyspareunia Treatment Major Product Offerings
  7.1.4 TherapeuticsMD Inc Dyspareunia Treatment Revenue in Global (2016-2021)
  7.1.5 TherapeuticsMD Inc Key News
7.2 AbbVie Inc.
  7.2.1 AbbVie Inc. Corporate Summary
  7.2.2 AbbVie Inc. Business Overview
  7.2.3 AbbVie Inc. Dyspareunia Treatment Major Product Offerings
  7.2.4 AbbVie Inc. Dyspareunia Treatment Revenue in Global (2016-2021)
  7.2.5 AbbVie Inc. Key News
7.3 Laboratories VIVACY
  7.3.1 Laboratories VIVACY Corporate Summary
  7.3.2 Laboratories VIVACY Business Overview
  7.3.3 Laboratories VIVACY Dyspareunia Treatment Major Product Offerings
  7.3.4 Laboratories VIVACY Dyspareunia Treatment Revenue in Global (2016-2021)
  7.3.5 Laboratories VIVACY Key News
7.4 GTO Pharmaceutical LLC
  7.4.1 GTO Pharmaceutical LLC Corporate Summary
  7.4.2 GTO Pharmaceutical LLC Business Overview
  7.4.3 GTO Pharmaceutical LLC Dyspareunia Treatment Major Product Offerings
  7.4.4 GTO Pharmaceutical LLC Dyspareunia Treatment Revenue in Global (2016-2021)
  7.4.5 GTO Pharmaceutical LLC Key News
7.5 Hormos Medical Oy (QuatRx Pharmaceuticals)
  7.5.1 Hormos Medical Oy (QuatRx Pharmaceuticals) Corporate Summary
  7.5.2 Hormos Medical Oy (QuatRx Pharmaceuticals) Business Overview
  7.5.3 Hormos Medical Oy (QuatRx Pharmaceuticals) Dyspareunia Treatment Major Product Offerings
  7.5.4 Hormos Medical Oy (QuatRx Pharmaceuticals) Dyspareunia Treatment Revenue in Global (2016-2021)
  7.5.5 Hormos Medical Oy (QuatRx Pharmaceuticals) Key News
7.6 EndoCeutics Inc
  7.6.1 EndoCeutics Inc Corporate Summary
  7.6.2 EndoCeutics Inc Business Overview
  7.6.3 EndoCeutics Inc Dyspareunia Treatment Major Product Offerings
  7.6.4 EndoCeutics Inc Dyspareunia Treatment Revenue in Global (2016-2021)
  7.6.5 EndoCeutics Inc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Dyspareunia Treatment Market Opportunities & Trends in Global Market
Table 2. Dyspareunia Treatment Market Drivers in Global Market
Table 3. Dyspareunia Treatment Market Restraints in Global Market
Table 4. Key Players of Dyspareunia Treatment in Global Market
Table 5. Top Dyspareunia Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Dyspareunia Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Dyspareunia Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Dyspareunia Treatment Product Type
Table 9. List of Global Tier 1 Dyspareunia Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dyspareunia Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Dyspareunia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Dyspareunia Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Dyspareunia Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Dyspareunia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Dyspareunia Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Dyspareunia Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Dyspareunia Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Dyspareunia Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Dyspareunia Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Dyspareunia Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Dyspareunia Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Dyspareunia Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Dyspareunia Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Dyspareunia Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Dyspareunia Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Dyspareunia Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Dyspareunia Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Dyspareunia Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Dyspareunia Treatment Revenue, (US$, Mn), 2022-2027
Table 30. TherapeuticsMD Inc Corporate Summary
Table 31. TherapeuticsMD Inc Dyspareunia Treatment Product Offerings
Table 32. TherapeuticsMD Inc Dyspareunia Treatment Revenue (US$, Mn), (2016-2021)
Table 33. AbbVie Inc. Corporate Summary
Table 34. AbbVie Inc. Dyspareunia Treatment Product Offerings
Table 35. AbbVie Inc. Dyspareunia Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Laboratories VIVACY Corporate Summary
Table 37. Laboratories VIVACY Dyspareunia Treatment Product Offerings
Table 38. Laboratories VIVACY Dyspareunia Treatment Revenue (US$, Mn), (2016-2021)
Table 39. GTO Pharmaceutical LLC Corporate Summary
Table 40. GTO Pharmaceutical LLC Dyspareunia Treatment Product Offerings
Table 41. GTO Pharmaceutical LLC Dyspareunia Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Hormos Medical Oy (QuatRx Pharmaceuticals) Corporate Summary
Table 43. Hormos Medical Oy (QuatRx Pharmaceuticals) Dyspareunia Treatment Product Offerings
Table 44. Hormos Medical Oy (QuatRx Pharmaceuticals) Dyspareunia Treatment Revenue (US$, Mn), (2016-2021)
Table 45. EndoCeutics Inc Corporate Summary
Table 46. EndoCeutics Inc Dyspareunia Treatment Product Offerings
Table 47. EndoCeutics Inc Dyspareunia Treatment Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Dyspareunia Treatment Segment by Type
Figure 2. Dyspareunia Treatment Segment by Application
Figure 3. Global Dyspareunia Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Dyspareunia Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Dyspareunia Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dyspareunia Treatment Revenue in 2020
Figure 8. By Type - Global Dyspareunia Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Dyspareunia Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Dyspareunia Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Dyspareunia Treatment Revenue Market Share, 2016-2027
Figure 12. US Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Dyspareunia Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Dyspareunia Treatment Revenue Market Share, 2016-2027
Figure 24. China Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Dyspareunia Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Dyspareunia Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Dyspareunia Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. TherapeuticsMD Inc Dyspareunia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AbbVie Inc. Dyspareunia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Laboratories VIVACY Dyspareunia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GTO Pharmaceutical LLC Dyspareunia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Hormos Medical Oy (QuatRx Pharmaceuticals) Dyspareunia Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications